With the progression of tumor treatment, the 5-year survival rate of breast cancer is close to
90%. Cardiovascular toxicity caused by chemotherapy has become a vital factor affecting …

Simple Summary Cancer therapy-related cardiac dysfunction (CTRCD) has been an urgent
medical issue in patients that receive breast cancer therapies including anthracycline-based …

Although anthracyclines are important anticancer agents, their use is limited due to various
adverse effects, particularly cardiac toxicity. Mechanisms underlying anthracycline-induced …

Serum biomarkers represent a reproducible, sensitive, minimally invasive and inexpensive
method to explore possible adverse cardiovascular effects of antineoplastic treatments. They …

PURPOSE Chemotherapy-induced peripheral neuropathy (CIPN) poses a substantial
challenge in breast cancer (BC) chemotherapy, affecting the patient's quality of life. Recent …

Background and Objectives: Anthracycline chemotherapy is a cornerstone in pediatric
oncology but carries a significant risk of cardiotoxicity. The early detection of cardiac …

Background: Chemotherap ym ay cause systemic inflammation. Therefore, reliabl em arker
sm onitoring inflammation during cancer treatment are intensively investigated. In our study …

Cancer survivors are at a much greater risk of developing cardiovascular diseases due to
cardiotoxic chemotherapy. Anthracyclines, antimetabolites and alkylating agents are known …

RESUMO O tratamento clínico do câncer de mama é baseado na cirurgia, radioterapia,
hormonioterapia, e terapia sistêmica. A quimioterapia neoadjuvante (QTneo) tem como …

In this paper, an automatic judgment algorithm of English text is proposed, which is split and
filtered first, then extracted and optimized, and finally interactively fused, and a BP neural …